日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chasing clues : Dementia unveils PML long after R‐CHOP treatment

追寻线索:痴呆症在R-CHOP治疗后很久才揭示PML

Oguejiofor, Kenneth; Galletta-Williams, Henry; Dovedi, Simon J; Roberts, Darren L; Stern, Peter L; West, Catharine M L; T, Swathi Sr; Swathi, Thamil Pavai

Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?

免疫疗法是否有可能改变人乳头瘤病毒 (HPV) 感染和上皮内瘤变的治疗格局?

Stern, Peter L

Modeling genetic epileptic encephalopathies using brain organoids

利用脑类器官模拟遗传性癫痫性脑病

Daniel J Steinberg ,Srinivasarao Repudi ,Afifa Saleem ,Irina Kustanovich ,Sergey Viukov ,Baraa Abudiab ,Ehud Banne ,Muhammad Mahajnah ,Jacob H Hanna ,Shani Stern ,Peter L Carlen ,Rami I Aqeilan

Harnessing immunity for therapy in human papillomavirus driven cancers

利用免疫力治疗人乳头瘤病毒驱动的癌症

Stern, Peter L

Welcome to Tumour Virus Research

欢迎来到肿瘤病毒研究

Stern, Peter L; Banks, Lawrence

Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma

T细胞与PD-L1表达细胞之间的空间邻近性可作为口咽鳞状细胞癌的预后生物标志物

Tsakiroglou, Anna Maria; Fergie, Martin; Oguejiofor, Ken; Linton, Kim; Thomson, David; Stern, Peter L; Astley, Susan; Byers, Richard; West, Catharine M L

Correction to: Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer

更正:抗体药物偶联物(A1mcMMAF)靶向癌胚糖蛋白5T4与卡铂联合治疗可提高卵巢癌异种移植模型的生存率

Wan, Y Louise; Sapra, Puja; Bolton, James; Chua, Jia Xin; Durrant, Lindy G; Stern, Peter L

Progress in eliminating HPV-associated disease

在消除HPV相关疾病方面取得的进展

Stern, Peter L; Canfell, Karen

Opportunities and challenges for human papillomavirus vaccination in cancer

人乳头瘤病毒疫苗在癌症治疗中的机遇与挑战

Roden, Richard B S; Stern, Peter L

The failure of radical treatments to cure cancer: can less deliver more?

根治癌症的疗法失败了:少即是多?

Dalgleish, Angus G; Stern, Peter L